BTI
ZLAB icon

Blue Trust Inc’s Zai Lab ZLAB Stock Holding History

Blue Trust Inc’s Portfolio ZLAB Stock Details ZLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$95 Hold
5
– – ﹤0.01% 2409
2026
Q1 		$94 Hold
5
– – ﹤0.01% 2456
2025
Q4 		$88 Hold
5
– – ﹤0.01% 2503
2025
Q3 		$169 Hold
5
– – ﹤0.01% 2520
2025
Q2 		$175 Sell
5
-377
-99% -$12.4K ﹤0.01% 2386
2025
Q1 		$13.8K Hold
382
– – ﹤0.01% 1774
2024
Q4 		$10K Buy
382
+141
+59% +$3.91K ﹤0.01% 1862
2024
Q3 		$4.18K Buy
241
+209
+653% +$3.95K ﹤0.01% 2446
2024
Q2 		$513 Buy
32
+27
+540% +$475 ﹤0.01% 2615
2024
Q1 		$80 Sell
5
-226
-98% -$4.76K ﹤0.01% 2120
2023
Q4 		$5K Sell
231
-775
-77% -$20.5K ﹤0.01% 1880
2023
Q3 		$28K Buy
1,006
+839
+502% +$22.3K ﹤0.01% 1068
2023
Q2 		$6K Buy
167
+57
+52% +$1.86K ﹤0.01% 1499
2023
Q1 		$3K Sell
110
-476
-81% -$18.3K ﹤0.01% 1963
2022
Q4 		$20K Buy
586
+393
+204% +$12.4K ﹤0.01% 1305
2022
Q3 		$7K Buy
193
+124
+180% +$5.3K ﹤0.01% 1488
2022
Q2 		$3K Buy
+69
New +$2.43K ﹤0.01% 1609

Other funds holding ZLAB

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Blue Trust Inc's ZLAB Position: Q2 2026 in Review

Blue Trust Inc held its Zai Lab (ZLAB) position steady in Q2 2026 at 5 shares worth $95. The position accounts for ﹤0.01% of the portfolio, ranked #2409.

Blue Trust Inc first reported a position in ZLAB in Q2 2022 and has held it in 17 quarters since. The position peaked at $28K in Q3 2023. 93 funds tracked by Wall St. Rank hold ZLAB as of Q2 2026.

  • Blue Trust Inc held 5 shares of Zai Lab worth $95 as of Q2 2026.
  • Blue Trust Inc left its Zai Lab share count unchanged in Q2 2026.
  • Zai Lab made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #2409 holding.
  • Blue Trust Inc first reported a position in Zai Lab in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Zai Lab position peaked at $28K in Q3 2023.
  • 93 funds tracked by Wall St. Rank held Zai Lab as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.